Corient Private Wealth
CME icon

Corient Private Wealth’s CME Group CME Stock Holding History

Corient Private Wealth’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.4M Sell
157,641
-144,495
-48% -$42.9M 0.07% 249
2025
Q4 		$80.7M Buy
302,136
+174,549
+137% +$47.4M 0.05% 284
2025
Q3 		$32.3M Buy
127,587
+34,474
+37% +$9.38M 0.05% 302
2025
Q2 		$25.7M Sell
93,113
-4,405
-5% -$1.2M 0.03% 347
2025
Q1 		$25.9M Buy
97,518
+3,950
+4% +$974K 0.04% 346
2024
Q4 		$21.7M Buy
93,568
+845
+0.9% +$194K 0.04% 379
2024
Q3 		$20.5M Sell
92,723
-6,216
-6% -$1.29M 0.03% 416
2024
Q2 		$19.5M Sell
98,939
-5,407
-5% -$1.12M 0.03% 389
2024
Q1 		$22.5M Sell
104,346
-1,080
-1% -$227K 0.04% 361
2023
Q4 		$22.2M Buy
105,426
+17,115
+19% +$3.65M 0.04% 369
2023
Q3 		$17.7M Sell
88,311
-6,588
-7% -$1.31M 0.04% 374
2023
Q2 		$17.6M Buy
94,899
+9,210
+11% +$1.7M 0.04% 371
2023
Q1 		$16.4M Buy
85,689
+5,959
+7% +$1.08M 0.04% 351
2022
Q4 		$13.4M Buy
+79,730
New +$13.9M 0.05% 322

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Corient Private Wealth's CME Position: Q1 2026 in Review

Corient Private Wealth reduced its CME Group (CME) stake by 48% in Q1 2026, selling an estimated $42.9M and leaving 157,641 shares worth $46.4M. The position accounts for 0.07% of the portfolio, ranked #249.

Corient Private Wealth first reported a position in CME in Q4 2022 and has held it in 14 quarters since. The position peaked at $80.7M in Q4 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Corient Private Wealth held 157,641 shares of CME Group worth $46.4M as of Q1 2026.
  • Corient Private Wealth sold 144,495 CME Group shares in Q1 2026, an estimated $42.9M.
  • CME Group made up 0.07% of Corient Private Wealth's portfolio in Q1 2026, its #249 holding.
  • Corient Private Wealth first reported a position in CME Group in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's CME Group position peaked at $80.7M in Q4 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.